DE60334220D1 - Rationell konstruierte, von chondroitinase b abgeleitete lyasen - Google Patents

Rationell konstruierte, von chondroitinase b abgeleitete lyasen

Info

Publication number
DE60334220D1
DE60334220D1 DE60334220T DE60334220T DE60334220D1 DE 60334220 D1 DE60334220 D1 DE 60334220D1 DE 60334220 T DE60334220 T DE 60334220T DE 60334220 T DE60334220 T DE 60334220T DE 60334220 D1 DE60334220 D1 DE 60334220D1
Authority
DE
Germany
Prior art keywords
chondroitinase
inhibiting
rationally constructed
relates
lyases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60334220T
Other languages
English (en)
Inventor
Kevin Pojasek
Rahul Raman
Ram Sasisekharan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Application granted granted Critical
Publication of DE60334220D1 publication Critical patent/DE60334220D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE60334220T 2002-06-03 2003-06-03 Rationell konstruierte, von chondroitinase b abgeleitete lyasen Expired - Lifetime DE60334220D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38550902P 2002-06-03 2002-06-03
PCT/US2003/017680 WO2003102160A2 (en) 2002-06-03 2003-06-03 Rationally designed polysaccharide lyases derived from chondroitinase b

Publications (1)

Publication Number Publication Date
DE60334220D1 true DE60334220D1 (de) 2010-10-28

Family

ID=29712183

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60334220T Expired - Lifetime DE60334220D1 (de) 2002-06-03 2003-06-03 Rationell konstruierte, von chondroitinase b abgeleitete lyasen

Country Status (7)

Country Link
US (4) US6962699B2 (de)
EP (1) EP1532241B1 (de)
AT (1) ATE481478T1 (de)
AU (1) AU2003243396A1 (de)
CA (1) CA2493509C (de)
DE (1) DE60334220D1 (de)
WO (1) WO2003102160A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566406B1 (en) * 1998-12-04 2003-05-20 Incept, Llc Biocompatible crosslinked polymers
EP1109919A2 (de) * 1998-08-27 2001-06-27 Massachusetts Institute Of Technology Von heparinase i und ii abgeleitete heparinasen
CA2370539C (en) 1999-04-23 2009-01-06 Massachusetts Institute Of Technology System and method for notating polymers
CA2402160C (en) * 2000-03-08 2012-02-14 Massachusetts Institute Of Technology Heparinase iii and uses thereof
AU2001292618A1 (en) * 2000-09-12 2002-03-26 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
AU2440802A (en) * 2000-10-18 2002-04-29 Massachusetts Inst Technology Methods and products related to pulmonary delivery of polysaccharides
EP1575534B1 (de) * 2002-05-03 2013-04-10 Massachusetts Institute Of Technology D4,5 glycuronidase und ihre verwendungen
DE60336341D1 (de) 2002-05-04 2011-04-21 Acorda Therapeutics Inc Zusammensetzungen und verfahren zur förderung des neuronalen wachstums
WO2004055491A2 (en) * 2002-05-20 2004-07-01 Massachusetts Institute Of Technology Novel method for sequence determination using nmr
CA2493509C (en) * 2002-06-03 2010-03-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from chondroitinase b
AU2003265561A1 (en) * 2002-08-15 2004-03-03 Acorda Therapeutics, Inc. Chimeric protein
JP4606712B2 (ja) * 2003-01-08 2011-01-05 マサチューセッツ インスティテュート オブ テクノロジー ２−ｏスルファターゼ組成物および関連の方法
AU2016204464B2 (en) * 2003-05-16 2018-03-22 Acorda Therapeutics, Inc. Proteoglycan degrading mutants for treatment of cns
EP1631234B1 (de) * 2003-05-16 2011-09-14 Acorda Therapeutics, Inc. Zusammensetzungen und verfahren zur behandlung von zns-schäden
US7959914B2 (en) 2003-05-16 2011-06-14 Acorda Therapeutics, Inc. Methods of reducing extravasation of inflammatory cells
AU2004247026B2 (en) 2003-05-16 2009-09-24 Acorda Therapeutics, Inc. Proteoglycan degrading mutants for treatment of CNS
US20070161599A1 (en) * 2003-05-28 2007-07-12 The Board Of Trustees Of The University Of Illinois Composition for blocking hiv binding to dendritic cells and methods of use thereof
EP1737954A2 (de) * 2004-03-10 2007-01-03 The Massachusetts Institute Of Technology Rekombinante chondroitinase abc i und verwendungen davon
US20060127950A1 (en) 2004-04-15 2006-06-15 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
WO2005111627A2 (en) * 2004-04-15 2005-11-24 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
WO2005110438A2 (en) * 2004-04-15 2005-11-24 Massachusetts Institute Of Technology Methods and products related to the intracellular delivery of polysaccharides
WO2005112986A2 (en) 2004-05-18 2005-12-01 Acorda Therapeutics, Inc. Purifying chondroitinase and stable formulations thereof
CA2614068A1 (en) 2004-06-29 2006-08-24 Massachusetts Institute Of Technology Methods and compositions related to the modulation of intercellular junctions
WO2006083328A2 (en) * 2004-09-15 2006-08-10 Massachusetts Institute Of Technology Biologically active surfaces and methods of their use
AU2006294755B2 (en) 2005-09-26 2012-04-19 Acorda Therapeutics, Inc. Compositions and methods of using chondroitinase ABCI mutants
WO2007120478A2 (en) * 2006-04-03 2007-10-25 Massachusetts Institute Of Technology Glycomic patterns for the detection of disease
WO2008045970A2 (en) 2006-10-10 2008-04-17 Acorda Therapeutics, Inc. Compositions and methods of using chondroitinase abci mutants
CA2674493C (en) * 2007-01-05 2017-05-09 Massachusetts Institute Of Technology Compositions of and methods of using sulfatases from flavobacterium heparinum
WO2009025888A2 (en) 2007-05-10 2009-02-26 The Arizona Board Of Regents For And On Behalf Of Arizona State University Regulated synthesis of antigen and/or regulated attentuation to enhance vaccine immunogenics and/or safety
GB0712302D0 (en) * 2007-06-22 2007-08-01 Cambridge Entpr Ltd Chrondroitinase polypeptides
US20090286289A1 (en) * 2008-03-10 2009-11-19 Pang Danny Z Production of Hyaluronate Unsaturated Disaccharides and its Application
US9045742B2 (en) * 2009-05-29 2015-06-02 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant Edwardsiella bacterium
US9796970B1 (en) 2017-04-24 2017-10-24 Advantek Serum Laboratories Ltd. Production of high purity chondroitinase ABC
CN111593040B (zh) * 2020-06-20 2022-08-30 山东大学 硫酸皮肤素裂解酶及其应用

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US91472A (en) * 1869-06-15 Improvement in plows
US91471A (en) * 1869-06-15 steigmeyer
US128225A (en) * 1872-06-25 Improvement in workmen s time-registers
US99628A (en) * 1870-02-08 Signors to themselves and a
US197933A (en) * 1877-12-11 Improvement in wood-screws
US92037A (en) * 1869-06-29 Improved shoe-pegging- machine
US8820A (en) * 1852-03-23 Improvement in friction-primers for cannon
US169143A (en) * 1875-10-26 Improvement in perforating stamps
US191587A (en) * 1877-06-05 Improvement in piano-forte bridges
US122793A (en) * 1872-01-16 Improvement in air-supplying attachments for stoves
US204869A (en) * 1878-06-11 Improvement in weighing-scales
US37376A (en) * 1863-01-06 Improvement in breech-loading fire-arms
JPS6031478B2 (ja) 1978-02-10 1985-07-22 生化学工業株式会社 純コンドロイチナ−ゼｂの製造法
US4341869A (en) 1980-08-25 1982-07-27 Massachusetts Institute Of Technology Process for producing heparinase
US5169772A (en) * 1988-06-06 1992-12-08 Massachusetts Institute Of Technology Large scale method for purification of high purity heparinase from flavobacterium heparinum
JP2726275B2 (ja) 1988-08-24 1998-03-11 生化学工業株式会社 グリコサミノグリカン分解酵素の精製法
JPH0693836B2 (ja) 1988-11-25 1994-11-24 新技術事業団 バチルス属に属するヘパリナーゼ生産微生物、新規ヘパリナーゼ及びその製法
ZA912770B (en) 1990-04-16 1992-01-29 Bethesda Eye Inst Enzymatic disinsertion of vitreous body
JPH04270327A (ja) 1991-02-26 1992-09-25 Fuji Photo Optical Co Ltd カメラの露出補正装置
JP3110064B2 (ja) 1991-03-06 2000-11-20 生化学工業株式会社 新規ヘパリチナーゼ、その製造法及びその生産菌
US5262325A (en) * 1991-04-04 1993-11-16 Ibex Technologies, Inc. Method for the enzymatic neutralization of heparin
US5668274A (en) 1991-04-23 1997-09-16 Akzo Nobel N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5714376A (en) 1991-10-23 1998-02-03 Massachusetts Institute Of Technology Heparinase gene from flavobacterium heparinum
US5496718A (en) * 1992-06-26 1996-03-05 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Chondroitinase ABC isolated from proteus vulgaris ATCC 6896
US5773277A (en) * 1992-06-26 1998-06-30 Seikagaku Kogyo Kabushiki Kaisha Crystalline chondroitinase isolated from Proteus vulgaris ATCC 6896
US6001630A (en) 1992-06-26 1999-12-14 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Pharmaceutical compositions of chondroitinase ABC isolated from Proteus vulgaris ATCC 6896
JP3419811B2 (ja) 1993-02-24 2003-06-23 マルハ株式会社 コンドロイチナーゼ遺伝子
US5389539A (en) * 1992-11-30 1995-02-14 Massachusetts Institute Of Technology Purification of heparinase I, II, and III from Flavobacterium heparinum
US5578480A (en) 1993-04-23 1996-11-26 American Cyanamid Company Methods for the isolation and purification of the recombinantly expressed chondroitinase I and II enzymes from P. vulgaris
HU219339B (en) 1993-09-30 2001-03-28 Seikagaku Kogyo Co Ltd Dermatan sulphate with low heparin or heparane sulphate content and pharmaceutical compositions comprising them
EP0726773A1 (de) 1993-11-17 1996-08-21 Massachusetts Institute Of Technology Verfahren zur hemmung der angiogenese mittels heparinase
US5498536A (en) 1994-04-22 1996-03-12 American Cyanamid Company Chondroitinase II from Proteus vulgaris
US5525500A (en) 1994-04-22 1996-06-11 American Cyanamid Company Chromatographic process for the copurification of chondroitinase I and II proteins from Proteus vulgaris
US5855883A (en) 1994-04-22 1999-01-05 American Cyanamid Company Method of disinsertion of vitreous body from neural retina of the eye with Proteus vulgaris chondroitinases I and II
US5681733A (en) * 1994-06-10 1997-10-28 Ibex Technologies Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum
US5619421A (en) 1994-06-17 1997-04-08 Massachusetts Institute Of Technology Computer-implemented process and computer system for estimating the three-dimensional shape of a ring-shaped molecule and of a portion of a molecule containing a ring-shaped structure
US6093563A (en) 1994-07-08 2000-07-25 Ibex Technologies R And D, Inc. Chondroitin lyase enzymes
US5997863A (en) 1994-07-08 1999-12-07 Ibex Technologies R And D, Inc. Attenuation of wound healing processes
US5965507A (en) 1995-06-08 1999-10-12 Procter & Gamble Company Cleaning compositions comprising chondroitinase
US6217863B1 (en) 1995-10-30 2001-04-17 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase I
US5866120A (en) 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
IT1285546B1 (it) 1996-01-16 1998-06-18 Alfa Wassermann Spa Uso del dermatano solfato a basso peso molecolare e delle specialita' medicinali che lo contengono nella terapia e nella prevenzione della
DE69829605T2 (de) 1997-05-02 2006-02-09 Seikagaku Corp. Chondroitinase enthaltende Zusammensetzungen
US6063378A (en) * 1997-08-22 2000-05-16 Seikagaku Corporation Therapeutic agent for herniated intervertebral disc
US5968822A (en) 1997-09-02 1999-10-19 Pecker; Iris Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
US6190875B1 (en) * 1997-09-02 2001-02-20 Insight Strategy & Marketing Ltd. Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
US6378527B1 (en) * 1998-04-08 2002-04-30 Chondros, Inc. Cell-culture and polymer constructs
WO1999058650A1 (en) 1998-05-13 1999-11-18 Biomarin Pharmaceuticals Lytic enzymes useful for treating fungal infections
JP2000044601A (ja) 1998-07-29 2000-02-15 Seikagaku Kogyo Co Ltd 新規ガラクトサミノグリカン
CA2370539C (en) 1999-04-23 2009-01-06 Massachusetts Institute Of Technology System and method for notating polymers
WO2001034781A2 (en) 1999-11-12 2001-05-17 Biomarin Pharmaceuticals Lytic enzymes useful for treating fungal infections
EP1231935B1 (de) 1999-11-17 2008-11-12 BioMarin Pharmaceutical Inc. Verminderung von angiogenese unter verwendung chondroitinsulfat abbauender enzyme
WO2001038399A1 (fr) 1999-11-24 2001-05-31 Seikagaku Corporation Procede de traitement des maladies des tissus superficiels
JP2004504262A (ja) 1999-12-02 2004-02-12 アイベックス　テクノロジーズ，　インコーポレイテッド 線維芽細胞の増殖の弱毒化
CA2397562A1 (en) 2000-01-21 2001-07-26 Ibex Pharmaceuticals, Inc. Flavobacterium heparinum expression system
CA2402160C (en) * 2000-03-08 2012-02-14 Massachusetts Institute Of Technology Heparinase iii and uses thereof
AU2001292618A1 (en) 2000-09-12 2002-03-26 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
AU2440802A (en) 2000-10-18 2002-04-29 Massachusetts Inst Technology Methods and products related to pulmonary delivery of polysaccharides
JP2005503120A (ja) 2001-03-27 2005-02-03 マサチューセッツ　インスティテュート　オブ　テクノロジー Ｆｇｆダイマー化に関する方法及び生成物
EP1438387A4 (de) * 2001-09-14 2004-10-13 Momenta Pharmaceuticals Inc Verfahren zur herstellung von glycomolekülen mit verstärkten aktivitäten und verwendungen davon
US20040214228A9 (en) 2001-09-14 2004-10-28 Ganesh Venkataraman Methods of evaluating glycomolecules for enhanced activities
GB0205022D0 (en) 2002-03-04 2002-04-17 Univ Cambridge Tech Materials and methods for the treatment of cns damage
EP2284535A1 (de) 2002-03-11 2011-02-16 Momenta Pharmaceuticals, Inc. Heparine mit niedrigem Molekulargewicht
CA2483271A1 (en) 2002-04-25 2003-11-06 Momenta Pharmaceuticals, Inc. Methods and products for mucosal delivery
EP1575534B1 (de) * 2002-05-03 2013-04-10 Massachusetts Institute Of Technology D4,5 glycuronidase und ihre verwendungen
WO2004055491A2 (en) 2002-05-20 2004-07-01 Massachusetts Institute Of Technology Novel method for sequence determination using nmr
CA2493509C (en) 2002-06-03 2010-03-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from chondroitinase b
WO2004066808A2 (en) 2002-12-20 2004-08-12 Momenta Pharmaceuticals, Inc. Glycan markers for diagnosing and monitoring disease
JP4606712B2 (ja) 2003-01-08 2011-01-05 マサチューセッツ インスティテュート オブ テクノロジー ２−ｏスルファターゼ組成物および関連の方法
KR100846449B1 (ko) * 2003-03-27 2008-07-16 삼성전자주식회사 휴대용 복합장치의 웹 카메라 모드 설정방법
AU2004247026B2 (en) 2003-05-16 2009-09-24 Acorda Therapeutics, Inc. Proteoglycan degrading mutants for treatment of CNS
US7407810B2 (en) 2003-09-04 2008-08-05 Momenta Pharmaceuticals, Inc. Methods and apparatus for characterizing polymeric mixtures
US7851223B2 (en) 2004-02-27 2010-12-14 Roar Holding Llc Method to detect emphysema
AU2005219413A1 (en) 2004-03-02 2005-09-15 Massachusetts Institute Of Technology Nanocell drug delivery system
WO2005112986A2 (en) 2004-05-18 2005-12-01 Acorda Therapeutics, Inc. Purifying chondroitinase and stable formulations thereof

Also Published As

Publication number Publication date
WO2003102160A3 (en) 2004-09-16
CA2493509A1 (en) 2003-12-11
WO2003102160A2 (en) 2003-12-11
US20040091472A1 (en) 2004-05-13
US20050233419A1 (en) 2005-10-20
EP1532241A4 (de) 2005-12-14
US20070065424A1 (en) 2007-03-22
CA2493509C (en) 2010-03-09
AU2003243396A8 (en) 2003-12-19
US20050227320A1 (en) 2005-10-13
US7129335B2 (en) 2006-10-31
EP1532241B1 (de) 2010-09-15
AU2003243396A1 (en) 2003-12-19
US7105334B2 (en) 2006-09-12
US6962699B2 (en) 2005-11-08
ATE481478T1 (de) 2010-10-15
EP1532241A2 (de) 2005-05-25

Similar Documents

Publication Publication Date Title
DE60334220D1 (de) Rationell konstruierte, von chondroitinase b abgeleitete lyasen
Pereira et al. Structure and anticoagulant activity of a sulfated galactan from the red alga, Gelidium crinale. Is there a specific structural requirement for the anticoagulant action?
DK1319183T3 (da) Fremgangsmåder og produkter relateret til heparin med lav molekylvægt
WO2005087920A3 (en) Recombinant chondroitinase abc i and uses thereof
NO20055722D0 (no) Antiseptiske preparater, fremgangsmater og systemer
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
WO2001066772A3 (en) Heparinase iii and uses thereof
DE60332168D1 (de) Adaptives filtersystem für reklamenachrichten
ATE490786T1 (de) Behandlung von verletzungen des zentralen nervensystems
NO20070551L (no) Vaksinesammensetninger og fremgangsmater for behandling av koronavirus infeksjon.
ITBO20020620A1 (it) Condotto multi-canale bioriassorbibile di rigenerazione del nervo e processo per preparare il medesimo.
NO20000752D0 (no) Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser
BRPI0409655A (pt) compostos heterocìclicos de ligação ao receptor para quimiocina com maior eficiência
ATE308329T1 (de) Verwendung von cellulosesulfat und andere sulfatierte polysaccharide zu vorbeugung und behandlung von pappiloma-virus-infektionen
AR050796A1 (es) Procedimiento de produccion del polisacarido k5
DK0897393T3 (da) Derivater af K5-polysaccharid med antikoagulerende aktivitet
ES2193958T3 (es) Inmunoadsorbentes para el tratamiento de la septicemia.
SE9904581D0 (sv) A novel helicobacter pylori-binding substance and use thereof
DK1366082T3 (da) Höjsulfaterede derivater af K5-polysaccharid og deres fremstilling
DK1165112T3 (da) Modulatorer af polysaccharider og anvendelser deraf
AR021692A1 (es) Tiorredoxina y procesamiento de granos
ITMI20030661A1 (it) Processo per la preparazione della ferutinina da piante del genere ferula
DE60039437D1 (de) Verwendung der sulfatierten polysacchariden zur behandlung von thrombosen
ATE392212T1 (de) Verwendung eines proteasom-inhibitors zur behandlung fibrotischer erkrankungen
DK1658494T3 (da) Fremgangsmåde til en in vitro titrering af en NCTA og anvendelse deraf i en fremgangsmåde til evalueringen og/eller monitorering af en biologisk produktproduktionsfremgangsmåde